Optimizing Clearance for Protein-Bound Molecules Using Cascade Filtration Therapy
AssigneeEdwards Lifesciences Corporation
InventorJean-Michel Lannoy
Life of this patent
Estimating the term…
Loading patent…
AssigneeEdwards Lifesciences Corporation
InventorJean-Michel Lannoy
Estimating the term…
A hemofiltration system or method removes unwanted molecules from a flow of blood using cascaded first and second hemofilters. Filtration of the blood in first hemofilter raises hemoconcentration of unwanted protein-bound molecules. Combination of a substitution fluid with outflow from the first hemofilter creates a concentration differential between bound and unbound molecules that frees unwanted molecules from protein bonds. Filtration of the combined fluids in a second hemofilter removes the unwanted free molecules. A second substitution fluid may be added to the twice filtered blood fluid for return to a patient. Removal of inflammatory mediators, apoptotic mediators, and certain electrolytes may be effected, and the removal may be optimized by controlling fluid flows and transmembrane pressures.
An extracorporeal blood filtration system for removing unwanted molecules from a flow of blood from a patient, comprising:
A method for optimizing removal of unwanted molecules from a flow of blood, the method comprising steps of:
A method of removing unwanted molecules from blood, comprising:
Dependencies are inferred from the claim text.